Work

Evaluation of a novel transcriptomic tumor signature (PROSTest) as response biomarker for 177Lu-PSMA therapy in advanced prostate cancer.

Year: 2023

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2023.41.6_suppl.183

Authors: Alin Chirindel, Mark Kidd, Cyrill A. Rentsch, Frank Stenner, Arnoud J. Templeton, Egbert Nitzsche, Damian Wild, Guillaume Nicolas, Irvin Mark Modlin

Institutions: University Hospital of Basel, Wren Laboratories (United States), St. Claraspital, Kantonsspital Aarau, Yale University

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4324137015

Cites:

Cited by: 2

Related to: 10